Philip Morris beats Q1 expectations despite U.S. nicotine pouch shipment drop

What happened

Philip Morris International posted adjusted earnings of $1.96 per share in the first quarter, beating analyst expectations of $1.83. Revenue climbed 9.1% to $10.15 billion, ahead of the $9.91 billion forecast. The company's smoke-free products now represent 43% of total revenue, with international smoke-free sales jumping 25%. The IQOS heated tobacco device showed strong momentum, surpassing Marlboro as the top nicotine brand in markets where it's available. The company maintained its full-year earnings guidance of $8.36 to $8.51 per share, in line with analyst forecasts.

Why the stock moved

The stock initially rose 2.8% in premarket trading following the earnings beat. However, investor sentiment appears mixed due to a significant challenge in the U.S. market. Shipments of Zyn nicotine pouches dropped nearly 24% during the quarter, even as industry data showed consumer demand for the product was increasing. Overall U.S. smoke-free shipment volumes fell 21%, dragging down domestic revenue and profit. This disconnect between demand and shipments for a key growth product likely created uncertainty about Philip Morris's ability to capitalize on the nicotine pouch trend in its home market.

Bigger picture

Philip Morris is navigating a transition from traditional cigarettes to smoke-free alternatives, a shift that's progressing unevenly across geographies. Internationally, the strategy is working well, with smoke-free revenue surging 25% and IQOS gaining market leadership. But the U.S. market presents complications. The company said it's investing more in Zyn to improve its competitive position with new flavors and offerings, suggesting it faces intensifying competition in the rapidly growing nicotine pouch category. The gap between rising consumer demand and falling shipments hints at potential supply chain issues, regulatory hurdles, or market share losses that Philip Morris needs to address to sustain its smoke-free transformation.

What investors watch

Investors will monitor whether Philip Morris can resolve the mismatch between Zyn demand and shipments in upcoming quarters. The company's ability to capture nicotine pouch market share in the U.S. is critical, as this category represents a major growth opportunity in smoke-free products. Watch for updates on Zyn's competitive positioning, flavor expansion, and any supply or distribution improvements. Internationally, track whether IQOS can maintain its momentum against Marlboro and other competitors. The company noted minimal expected impact from Middle East tensions but flagged some cost increases in energy and transport, which could affect margins if geopolitical instability persists.

This article was generated by Quantli AI using publicly available news sources.